The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis

Joint Bone Spine

Volumn 79, Issue 4, 2012, Pages 370-374

  Lea, Wu in ^a   Lee, Young Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Ankylosing spondylitis; Interleukin 1; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; ASIA; EUROPE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INTERLEUKIN 1 ANTAGONIST GENE; INTERLEUKIN 1 GENE; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AND CENTRAL AMERICA; SYSTEMATIC REVIEW; VARIABLE NUMBER OF TANDEM REPEAT;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; ODDS RATIO; POLYMORPHISM, GENETIC; SPONDYLITIS, ANKYLOSING; TANDEM REPEAT SEQUENCES;

EID: 84863186333     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.06.010     Document Type: Article

References (30)

1. Brown M.A., Wordsworth B.P., Reveille J.D. Genetics of ankylosing spondylitis. Clin Exp Rheumatol 2002, 20:S43-S49.
2. Brown M.A., Laval S.H., Brophy S., et al. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000, 59:883-886.
3. Laval S.H., Timms A., Edwards S., et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001, 68:918-926.
4. Laurincova B. Interleukin-1 family: from genes to human disease. Acta Univ Palacki Olomuc Fac Med 2000, 143:19-29.
5. Smith D.E., Renshaw B.R., Ketchem R.R., et al. Four new members expand the interleukin-1 superfamily. J Biol Chem 2000, 275:1169-1175.
6. Lee Y.H., Ji J.D., Song G.G. Association between interleukin 1 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. J Rheumatol 2009, 36:12-15.
7. Guo Z.S., Li C., Lin Z.M., et al. Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population. Int J Immunogenet 2010, 37:33-37.
8. Sims A.M., Timms A.E., Bruges-Armas J., et al. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008, 67:1305-1309.
9. Agrawal S., Srivastava R., Sharma B., et al. IL1RN*2 allele of IL-1receptor antagonist VNTR polymorphism is associated with susceptibility to ankylosing [corrected] spondylitis in Indian patients. Clin Rheumatol 2008, 27:573-576.
10. Maksymowych W.P., Rahman P., Reeve J.P., et al. Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum 2006, 54:974-985.
11. Chou C.T., Timms A.E., Wei J.C., et al. Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese. Ann Rheum Dis 2006, 65:1106-1109.
12. Timms A.E., Crane A.M., Sims A.M., et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004, 75:587-595.
13. Maksymowych W.P., Reeve J.P., Reveille J.D., et al. High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheum 2003, 48:2011-2018.
14. van der Paardt M., Crusius J.B., Garcia-Gonzalez M.A., et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford) 2002, 41:1419-1423.
15. McGarry F., Neilly J., Anderson N., et al. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 2001, 40:1359-1364.
16. Lee Y.H., Rho Y.H., Choi S.J., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis. Rheumatology (Oxford) 2007, 46:49-56.
17. Lee Y.H., Witte T., Momot T., et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum 2005, 52:3966-3974.
18. Lee Y.H., Harley J.B., Nath S.K. Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006, 14:364-371.
19. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
20. Tarlow J.K., Blakemore A.I., Lennard A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993, 91:403-404.
21. Arman A., Yilmaz B., Coker A., et al. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clin Exp Rheumatol 2006, 24:643-648.
22. Davey Smith G., Egger M. Meta-analyses of randomised controlled trials. Lancet 1997, 350:1182.
23. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
24. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
25. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
26. Kim T.J., Kim T.H., Lee H.J., et al. Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 2008, 35:1603-1608.
27. Kim T.H., Stone M.A., Rahman P., et al. Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea. J Rheumatol 2005, 32:1907-1910.
28. Jin L., Zhang G., Akey J.M., et al. Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. Arthritis Rheum 2004, 50:3047-3048.
29. Djouadi K., Nedelec B., Tamouza R., et al. Interleukin 1 gene cluster polymorphisms in multiplex families with spondylarthropathies. Cytokine 2001, 13:98-103.
30. Buchs N., di Giovine F.S., Silvestri T., et al. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2001, 2:222-228.